Approved Foreign Follow-On Biologics / Biosimilars
Biosimilars Approved In The E.U.
Ongavia (ranibizumab) (Teva / Bioeq) (May-2022 in the United Kingdom) Ranivisio (ranibizumab) (Teva / Bioeq) (August-2022)